Connect your AI

Veradermics MANE Repayments Of Notes Payable

Repayments Of Notes Payable at other companies

NexPoint Real Estate FinanceNREF

$36.5M—

KKR Real Estate Finance TrustKREF

$0—

CubeSmartCUBE

$308K+2.3%

FluorFLR

$0-100%

Bloom EnergyBE

$7.97M+198%

Equity ResidentialEQR

$4M+8.1%

Other financials

Income statement

Operating income-$29.9M-131%

Net income-$27.2M-120%

EPS (diluted)-$1.32+93.3%

Balance sheet

Cash & equivalents$168.4M+419%

Total debt$4.0K—

Total equity$390.6M+744%

Total assets$397.4M—

Cash flow

Operating cash flow-$21.2M-59.0%

CapEx--100%

Free cash flow-$21.2M-58.7%

Valuation

Market cap$3.92B—

Returns & leverage

Return on equity-28.7%—

Current ratio59.1×—

Where this comes from

Reported directly by Veradermics in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfNotesPayable.

The official record: Veradermics ’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veradermics 's repayments of notes payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Veradermics 's repayments of notes payable?: Veradermics (MANE) reported repayments of notes payable of $0 in Q4 2025.
How has Veradermics 's repayments of notes payable changed year-over-year?: Veradermics 's repayments of notes payable decreased by 100.0% year-over-year, from $211.25K to $0.